http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04275245-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1784eb7fc902d292db30e120ec712d5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-143
filingDate 1991-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd537f75c88055d8259a368673c006b0
publicationDate 1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04275245-A
titleOfInvention Asymmetric reduction of ketone compound
abstract PURPOSE: To inexpensively and simply produce and separate an optically active alcohol having different absolute configuration by subjecting a prochiral ketone compound to asymmetric reduction using a specific optically active ligand in an extremely small amount. n CONSTITUTION: A ketone compound, particularly aromatic ketone such as phenylmethyl ketone, phenylethyl ketone or phenylpropyl ketone is subjected to asymmetric reduction reaction into an optically active alcohol in the presence of 3-amide-2-hydroxybornane of exo body or endo body expressed by the formula at-100 to 100°C, preferably and temperature close to room temperature to provide an optically active alcohol having different absolute configuration. The compound expressed by the formula is preferably used in an amount of 0.01-0.5 equivalent weight per weight of ketone compound by selection of axo body or end body of the compound expressed by the formula. Borane is preferably used as a reducing agent and in this case, borane is previously added to the compound expressed by the formula in an equivalent amount and used as a complex. n COPYRIGHT: (C)1992,JPO&Japio
priorityDate 1991-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226456954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID235759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15352829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455667478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54391471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231475158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228991941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226812636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230815126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12160269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226572281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523150

Total number of triples: 46.